Epizyme 10K 2017 Annual report | EPZM Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: ACA, accident, advisor, ALK, alongside, AMT, anaemia, ancestry, anemia, antibiotic, antifungal, AstraZeneca, bar, bevacizumab, bidding, biopsy, bipartisan, birth, BLA, BMS, borrowing, Brexit, burden, Cadillac, calendar, carboplatin, CDER, CDRH, Century, chamber, chest, CNS, codified, commerce, copanlisib, Cornell, countermeasure, CSR, culture, deadline, developmental, diarrhoea, disaggregation, disorder, docetaxel, DSMB, dual, durvalumab, EGFR, eighteen, electorate, electrical, elicited, embryonic, Empliciti, excise, extinguishment, FDARA, fellowship, fetal, flat, formally, forum, Friday, fulfill, gemcitabine, Giordano, halved, hemoglobin, histiocytic, idealisib, IHC, IIIB, indemnification, indemnify, inherited, inoperable, Inspector, inter, interstate, IR, Ixempra, justification, leaving, Lisbon, men, Michael, monogenic, multi, neurological, nivolumab, NME, nonclinical, Notwithstanding, NSCLC, offshore, Opdivo, operationalized, organizational, overseen, paclitaxel, pain, paired, passage, passed, passing, PCAOB, pembrolizumab, PHSA, plc, poorly, pre, prognostic, prostate, PSP, QSR, qui, randomized, reactivation, Reauthorization, reauthorize, RECIST, red, reevaluate, reexamination, referendum, refine, regenerative, regime, remeasurement, repatriated, resistant, revaluation, revalue, rewriting, rodent, rolling, SCD, Secretary, securitization, Senate, session, shipment, shipped, shipping, shortage, silenced, sixty, speed, Sprycel, spur, stabilization, stroke, stronger, syndrome, tablet, taxation, tazemeotstat, TCJA, telecommunication, terrorism, thalassemia, thousand, threat, Title, tool, top, topological, toxicology, Trump, umbrella, unallocated, unambiguously, undermine, underway, undisclosed, unintentional, unscheduled, unvested, urge, variable, vinorelbine, Vitrisa, VOC, waive, waived, war, warrant, WO, women, Yervoy

Removed: andin, anin, attain, Avastin, bank, Banking, baseline, BeiGene, beneficially, biochemical, Blackstone, bone, California, cellular, Chaim, Chicago, commitment, concentration, concurrent, context, converted, Copeland, cytotoxic, death, defining, developingin, disrupting, driver, entrench, entry, enzymatic, eradicating, evolved, Excellence, excipient, faculty, feasibility, fellow, formation, Gould, Graduate, Hall, Harvard, heart, heavily, Herceptin, Ho, inclusive, indiscriminate, inhibited, inInternal, initiating, interfere, invented, invested, IPO, journalBlood, Kapnek, kidney, kill, killing, lacked, library, lymphatic, marrow, Metastagen, methyl, morein, move, MVC, notably, oncological, optimized, orin, orqui, Peter, Petkevitch, pharmacodynamic, pharmacological, pharmacology, placement, postdoctoral, preceding, Princeton, Pritzker, proliferating, ratable, ratably, ratio, RBC, relying, requiredin, Robertson, screening, Seton, Shansby, shortcoming, spread, stratification, survive, takeover, tandem, Tarceva, thesein, throughin, transferability, translation, Trust, uncontrolled, uponin, vascular, Weizmann, wide, Yale, Zaltrap

Epizyme (EPZM) 10-K2017 FY Annual report

Content analysis